Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Jordan Reimschisel
A Full Toolbox Will Speed Regenerative Medicine
By Adam Thierer and Jordan Reimschisel Headlines like one this week announcing the almost $12 billion purchase of Kite Pharma by Gilead Sciences showcase the growth and potential of cutting edge applications of genetic science; for example, reengineering a patient’s immune cells to better fight cancer.
Could Helping Hurt?
Using DNA Testing to Reunite Families May Backfire Last week, the public outcry against the Trump administration’s policy of separating children and parents accused of illegally crossing the border between Mexico and the United States reached its apex. Feeling the pressure, President Trump relented and signed an executive order ending the practice. In the months between the announcement of the “zero-tolerance” policy and its reversal, thousands of children were separated from their parents.
Tracking a Killer
Police Use of DNA and Forensic Genetics Source: Wikimedia Commons Many of us love exciting investigative dramas like Bones and Hawaii Five-0. The twists and turns, momentary dead ends, and dramatic reveal of new clues keeps us on the edge of our seats. But we also know that real life is different. Most of the time.
GDPR and Me: how the EU data rules could impact genetic testing
The EU’s new data privacy rules may hurt health technologies the hardest By Jennifer Huddleston Skees and Jordan Reimschisel Each day seems to bring a new “data privacy scandal.” During his testimony before Congress, Facebook’s Mark Zuckerberg was repeatedly pressed on whether the United States should adopt the zealous privacy standards of the European Union’s General Data Protection Regulation (GDPR).
“Build & Freeze” Regulation Versus Iterative Innovation
What happens when analog era regulation collides with digital age technologies? The short answer: Something’s got to give. Because if traditional command-and-control regulatory regimes don’t make room for iterative innovation, it will result in fewer life-enriching — even life-saving — medical products and health care services.
Most Americans Have No Idea How Genetic Technology Works - It’s About to Change Everything
In 2015, a groundbreaking study authored by several Chinese researchers sparked both imagination and concern in the world of genetic science and synthetic biology. The scientists had used a technology called CRISPR to modify the DNA of a days old human embryo. Just last week, British scientists published the latest experiment using CRISPR on embryos, following similar work in the United States.
The U.S. Ignores CRISPR and Genetic Engineering Issues to Its Own Detriment
Recent American experiments with genetically edited embryos have reignited both excitement and consternation over the possibility of modifying human DNA. Some scientists have called for extreme caution moving forward; others are responding by preparing kids for a new world that might soon include "Clustered Regularly Interspaced Short Palindromic Repeats," or CRISPR for short, biotechnology that allows for precise genetic engineering.
How the FDA Made a Felon Out of This Amish Farmer
In Bath County, Kentucky, a rural area near Lexington, a judge sentenced a 57-year-old Amish farmer and father of 12 to six years in prison for producing a herbal skin cream without the government’s permission. Samuel Girod formulated homemade skin-care products on his family farm, and sold them for two decades throughout the upper Midwest, largely on word-of-mouth promotion. He claimed that his products could help with poison ivy rashes, psoriasis, headaches, and more.
When it comes to tobacco and cigarettes, people are smarter than you think
In the last decade, the Food and Drug Administration has waged all-out war against the tobacco industry. When President Barack Obama signed the Family Smoking Prevention and Tobacco Control Act, he gave the agency unprecedented powers over tobacco companies. Last year the FDA finalized a rule that both extended their tobacco regulation authority and established an aggressive product review regime.
The True Goal of the FDA Should Be Drug Innovation | RealClearHealth
Last week, the Senate Committee on Health, Education, Labor, and Pensions met to consider legislation that would reauthorize the Food and Drug Administration’s (FDA) user fee programs. These programs make up a large part of the agency’s budget. This process will continue over the next several weeks. Earlier this month, the House Committee on Energy and Commerce also held a hearing to consider improvements to the regulation of medical technologies.
23andMe, the FDA and the Case of Easing Medical Innovation
The Food and Drug Administration announced on April 6 that it will allow the California-based genomics and biotechnology company 23andMe to sell direct-to-consumer tests for 10 genetic risks, including Parkinson's, late-onset Alzheimer's, Celiac and Gaucher type 1 diseases. Having this information may help customers prolong their lives, improve well-being and alleviate health-related costs.
Insurance costs just the tip of the iceberg. Time to reform the FDA.
The collapse of the House Republicans’ healthcare bill presents the White House and Congress with an opportunity to redirect reform toward more fertile ground. The Food and Drug Administration (FDA) is an ideal place to start, with the potential to attract bipartisan support. Healthcare is an iceberg. Insurance system costs rise above the water line. Beneath the surface lie 90 percent of the costs — payments to doctors, nurses, hospitals, laboratories, drugs and devices.
Federal regulators far behind technology curve
We stand on the cusp of a revolution in medical technologies are poised to expand significantly the range of life-enriching, and potentially even lifesaving, treatments. But it can’t happen unless we get serious about reforming public policies that limit these opportunities. Luckily, change might be on the way. In his first address to Congress, President Donald Trump slipped in a topic that had not received much of his attention: the Food and Drug Administration.
States Rebel Against Obama-Era Franchise Rule
State lawmakers are rising up in opposition to a federal rule which fundamentally changes how certain businesses contract together. Former President Barack Obama made major changes to labor law during his time in office. The International Franchise Association (IFA) has warned changes to the joint-employment standard could be devastating. It has since launched numerous initiatives in opposition to the change. The IFA has directly worked with state lawmakers as part of one such initiative.
Job Growth Remains Strong Under Trump With 235K New Jobs
The economy continued to show steady employment growth by gaining an additional 235,000 new jobs for the month of February, according to a federal report Friday. President Donald Trump entered office at a time of positive labor market growth. Former President Barack Obama oversaw the trend during his final years in office, following an irregularly prolonged economic recovery. The Bureau of Labor Statistics (BLS) found in its latest jobs report that the trend continued with 235,000 new jobs.
Women Skip Work During Nationwide Protest
Women in cities across the country skipped work to protest Wednesday against gender discrimination in the workplace. A Day Without a Woman protest aimed at highlighting how important women are to the workforce. Participants argued throughout the day that women are mistreated and undervalued at work. They pointed to the gender wage gap, and other forms of inequality women face. The national work stoppage is the latest in a series of protests that have occurred since the election.
Who is Protectionism Protecting Anyway?
“Take heed that we buy no more from strangers than we sell them, for so we impoverish ourselves and enrich them.” Although this sounds vaguely like Donald Trump talking about his trade policy, it was actually written by Sir Thomas Smith in 16th century England. Smith advocated a trade policy that enriched the merchant class and hurt the common people of England. Trump’s similar trade policy would have the same consequences for the American consumer.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Jordan
Contact Jordan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack